<DOC>
	<DOC>NCT00484107</DOC>
	<brief_summary>This post-marketing study will provide local safety and tolerance data on the use of PremarinÂ® vaginal cream.</brief_summary>
	<brief_title>Tolerability &amp; Safety of Premarin Vaginal Cream in Indian Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Patients in whom Premarin vaginal cream is indicated. In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study. Provide signed informed consent. Patients not willing to give informed consent.</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>